Clinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria.

Hdl Handle:
http://hdl.handle.net/10144/37453
Title:
Clinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria.
Authors:
Legros, D; Johnson, K; Houpikian, P; Makanga, M; Kabakyenga, J K; Talisuna, A O; Taylor, W R J
Journal:
Transactions of the Royal Society of Tropical Medicine and Hygiene
Abstract:
We conducted a 14-day study (during March-May 1998) to assess the efficacy of chloroquine and sulfadoxine-pyrimethamine (SP) for treating uncomplicated Plasmodium falciparum malaria in Uganda. Overall treatment failure rates were 43 (81.1%) of 53 chloroquine recipients and 16 (25.0%) of 64 SP patients. Strategies to improve the life-span of standard and affordable anti-malarial drugs are needed.
Affiliation:
Epicentre, P.O. Box 2362, Kampala, Uganda.
Issue Date:
2002
URI:
http://hdl.handle.net/10144/37453
PubMed ID:
12055815
Language:
en
ISSN:
0035-9203
Appears in Collections:
Malaria

Full metadata record

DC FieldValue Language
dc.contributor.authorLegros, D-
dc.contributor.authorJohnson, K-
dc.contributor.authorHoupikian, P-
dc.contributor.authorMakanga, M-
dc.contributor.authorKabakyenga, J K-
dc.contributor.authorTalisuna, A O-
dc.contributor.authorTaylor, W R J-
dc.date.accessioned2008-09-08T09:20:03Z-
dc.date.available2008-09-08T09:20:03Z-
dc.date.issued2002-
dc.identifier.citationClinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria., 96 (2):199-201 Trans. R. Soc. Trop. Med. Hyg.en
dc.identifier.issn0035-9203-
dc.identifier.pmid12055815-
dc.identifier.urihttp://hdl.handle.net/10144/37453-
dc.description.abstractWe conducted a 14-day study (during March-May 1998) to assess the efficacy of chloroquine and sulfadoxine-pyrimethamine (SP) for treating uncomplicated Plasmodium falciparum malaria in Uganda. Overall treatment failure rates were 43 (81.1%) of 53 chloroquine recipients and 16 (25.0%) of 64 SP patients. Strategies to improve the life-span of standard and affordable anti-malarial drugs are needed.en
dc.language.isoenen
dc.rightsPublished by Elsevier. Archived on this site with the kind permission of Elsevier Ltd. ([url]http://www.sciencedirect.com/science/journal/00359203[/url]) and the Royal Society of Tropical Medicine and Hygiene ([url]http://www.rstmh.org/transactions.asp[/url])en
dc.subject.meshAntimalarialsen
dc.subject.meshChild, Preschoolen
dc.subject.meshChloroquineen
dc.subject.meshDouble-Blind Methoden
dc.subject.meshDrug Combinationsen
dc.subject.meshFemaleen
dc.subject.meshHumansen
dc.subject.meshInfant, Newbornen
dc.subject.meshMalaria, Falciparumen
dc.subject.meshMaleen
dc.subject.meshPyrimethamineen
dc.subject.meshSulfadoxineen
dc.subject.meshTreatment Outcomeen
dc.titleClinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria.en
dc.contributor.departmentEpicentre, P.O. Box 2362, Kampala, Uganda.en
dc.identifier.journalTransactions of the Royal Society of Tropical Medicine and Hygieneen
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.